DISTRICT OF COLUMBIA PARTNERSHIP FOR AIDS PROGRESS (DC PFAP)

哥伦比亚特区艾滋病进展伙伴关系 (DC PFAP)

• 批准号: 10271466
• 负责人: ELANA ROSENTHAL
• 金额: $ 9.57万
• 依托单位: UNIVERSITY OF MARYLAND BALTIMORE
• 依托单位国家: 美国
• 财政年份: 2017
• 资助国家: 美国
• 起止时间: 2017-09-18 至 2021-09-17
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10271466
• 关键词: AIDS/HIV problem; Acquired Immunodeficiency Syndrome; Cities; Collaborations; Communicable Diseases; Critical Care; Data; Disease Outcome; District of Columbia; Extramural Activities; Funding; Goals; HIV; Harm Reduction; Hepatitis C virus; Intervention; Medicine; Modeling; Needs Assessment; Patients; Population; Research; Services; Site; United States National Institutes of Health; addiction; clinical center; comorbidity; improved; opioid use disorder; programs; urban area

The National Institutes of Health (NIH) Clinical Center, Critical Care Medicine Department (CCMD), manages a research program in the District of Columbia and at the Clinical Center, NIH entitled: District of Columbia Partnership for HIV/AIDS Progress (DC PFAP). This program is an intramural-extramural partnership which has the overall goal of performing research on how to reduce the number of new cases of HIV in the city, how to reduce the number of patients not successfully treated for HIV, and how to reduce the impact of HIV and its comorbidities on the population. The over-arching goal is to produce research that demonstrates a model that other urban areas can follow to reduce the burden of HIV/AIDS in their jurisdictions.

美国国立卫生研究院（NIH）临床中心重症监护医学部（CCMD）负责管理哥伦比亚特区和NIH临床中心的一项研究项目，该项目名为：哥伦比亚特区艾滋病毒/艾滋病进展伙伴关系（DC PFAP）。该计划是一个内部和外部的合作伙伴关系，其总体目标是研究如何减少该市艾滋病毒新发病例的数量，如何减少未成功治疗艾滋病毒的患者数量，以及如何减少艾滋病毒及其合并症对人口的影响。总体目标是开展研究，展示一种其他城市地区可以效仿的模式，以减轻其管辖范围内的艾滋病毒/艾滋病负担。